Biogen and Belgian partner UCB announce positive data from latestage trial of lupus treatment
Sep 24, 2024
Biogen Inc.’s stock rose 2% early Tuesday, after the company and Belgian partner UCB announced positive results in a late-stage trial
https://www.marketwatch.com/story/biogen-and-belgian-partner-ucb-announce-positive-data-from-late-stage-trial-of-lupus-treatment-d020ec55?mod=mw_rss_topstories
Respond, make new discussions, see other discussions and customize your news...

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service